Having trouble viewing this email? View in your browser.

27 March 2018

Dear colleagues,

ESCMID members may be interested to access the information on REVIVE, a hub developed by the Global Antibiotic Research & Development Partnership (GARDP) aimed at bringing together researchers and drug developers. The group also organizes webinars on topics in connection with the development of antibacterial drugs.

Your ESCMID communications editors


Register now for TAE Day 2018 at 13:15 on 21 April 2018 at ECCMID!

Don't miss this unique opportunity to get close to the experts and to learn about their career paths at TAE Day on 21 April at ECCMID. This is a popular session which gives younger professionals the chance to talk to experts in an informal setting. Participants can sign up for the expert table of their choice to talk about their career and will be able to submit optional questions that the moderator will receive before the session. Places are open to young scientist members and are limited so sign up now!

› Read more

ESGAP contributes to ebook on antibiotic stewardship with BSAC

The study group for antibiotic stewardship contributed to the ebook Antimicrobial Stewardship – from Principles to Practice, which the British Society for Antimicrobial Chemotherapy (BSAC) published last week. This ebook nicely complements ESGAP/ESCMID’s comprehensive book on antimicrobial stewardship that was published last year. You may download the BSAC ebook for free from the internet.

› Read more

CMI highlight: screening of migrants for resistant tuberculosis

Following the report of a cluster of multidrug-resistant tuberculosis (MDR-TB) among migrants, researchers at the European Centre for Disease Control evaluated if entry screening identified tuberculosis for different categories of migrants in European countries. Their assessment shows that 27 of 36 (75%) patients were screened for tuberculosis. Of these, 13 (50%) were diagnosed through the screening. Most patients were eventually diagnosed with multidrug-resistant tuberculosis within months of entry in the country. The researchers concluded that systematic screening of migrants at entry can identify tuberculosis but only captures active infection at entry. Thus access for migrants to the health system in the host countries should be ensured to allow early detection and treatment of cases and avoid further spread.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.